NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered GHK-Cu from NovaPeptide? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
78%
Finnrick rating
#143 of 156 GHK-Cu vendors
1 of 3 classifiable tests passed
natural 33% · customers 4.1★ (4)
methodology · Purity focus
Finnrick analysis · GHK-Cu

NovaPeptide's purity-focus record is strongest on Retatrutide, with Tirzepatide also clean but sparse, while the catalog signal is uneven across other peptides. BPC-157 improved after early purity misses, but Tesamorelin and GHK-Cu carry weaker evidence; recent testing helps, though batch documentation remains thin.

methodology →
vendor intelligence report
Vendor Intelligence Report: NovaPeptide

Two sister domains tell conflicting China-manufacturer and Delaware-biotech stories, while registry and WHOIS records point elsewhere. The report traces the virtual-office address, informal payment rails, and copycat coupon-page confusion buyers must verify.

18 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.73
84%
12
2
Tirzepatide
$2.50
80%
2
3
GHK-Cuselected
$0.05
78%
3
4
BPC-157
$0.64
53%
5
5
Tesamorelin
$1.50
44%
4
6
CJC-1295
$1.50
-
0
7
CJC-IPA
$0.99
-
0
8
Glutathione
$0.02
-
0
9
hCG
-
-
0
10
HGH
-
-
0
11
Ipamorelin
$0.65
-
0
12
KLOW
$0.25
-
0
13
NAD+
-
-
0
15
TB-500
$1.02
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%15 Sep 2026: 82%24 Sep 2026: 83%29 Sep 2026: 77%15 Nov 2026: current 78%82%78%Sep 26Nov 26
Showing GHK-Cu tests only
NovaPeptide GHK-Cu test history
COA-backed lab tests

About NovaPeptide test results from Finnrick

NovaPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 26 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible NovaPeptide peptides in this dataset are BPC-157 (5 tests), GHK-Cu (3 tests) and Retatrutide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 26 recent tests.

Corrections
No corrections.
Peptide testing

Ordered GHK-Cu from NovaPeptide? Mail in a sample (US only) and let us test it.

Test my supply